Languages
简体中文
繁體中文
English
日本語
한국어
Bahasa Indonesia
Tiếng Việt
Sign In
Send a Release
Products
News
Resources
Contact
Search
Search
Products
News
Resources
Contact
Overview
Content Creation
Distribution
Monitoring & Insights
Influencer Database
Falcon
All Products
Send a Release
News
Products
Resources
Contact
Overview
Latest
Regional
Mainland China
Japan
Korea
Indonesia
Malaysia
Singapore
Thailand
Vietnam
Australia
Industry
Auto & Transportation
Business Technology
Consumer Products & Retail
Consumer Technology
Energy
Entertainment & Media
Environment
Financial Services
General Business
Health
Heavy Industry & Manufacturing
Policy & Public Interest
Sports
Telecommunications
Travel
Food and Beverages
Advertising, Marketing and Media
Exhibition
Real Estate and Furniture
Trending Topics
Earnings
Artificial Intelligence
Virtual Reality (VR)
Co-Working Space
Belt & Road
Blockchain
Investment & Financing
Personnel Announcements
World Economic Forum
COVID-19 / Coronavirus
Live Streaming
New Technologies & New Products
Web Summit
Carbon Neutral
China International Consumer Products Expo
Biotech
Summer Event
Environmental, Social, Governance (ESG)
RE+ 2023
Sustainability
UN Climate Change Conference (COP28)
Embedded World
Lunar New Year
Mobile World Congress (MWC)
IFA 2023
Holiday Season
Consumer Electronics Show (CES)
Canton Fair
Earth Day
Mother's Day
Fortune Global 500/ Fortune China 500
Asian Games
China International Import Expo
5G
International Women's Day
Auto Shanghai 2023
World Environment Day
Multimedia
Other Languages
Malaysian
Thai
Public Company News
Send a Release
Resources
Products
News
Contact
Overview
Beyond PR Blog
Media Coffee
Client Stories
White Papers
Events in APAC
Media Room
Send a Release
Contact
Products
Resources
News
Asia Pacific Offices
Request More Information
Alert / Newsletter Subscription
Our Presence on Social Media Sites
FAQs
Send a Release
Products
News
Resources
Contact
Send a Release
齐鲁制药上海临床研究中心
Media Room
Latest News
Photo News
Photo News
Time
All
2024
2023
2022
Results from the Clinical Trial of Qilu Pharmaceutical's Novel Anticancer Agent Iparomlimab and Tuvonralimab (QL1706) Featured in Oral Presentation at the ESGO Annual Meeting
2024-03-04 16:53
1433
Report
Qilu Pharmaceutical announces the latest results from its clinical study on QL1706, in combination with chemotherapy, as a first-line treatment for recurrent or metastatic cervical cancer
2023-10-25 22:33
1862
Report
Qilu Pharmaceutical announces the latest results from its clinical study on QL1706, in combination with chemotherapy, as a first-line treatment for recurrent or metastatic cervical cancer
2023-10-25 22:15
1729
Report
Qilu Pharmaceutical Releases Latest Results of QL1706 plus Chemotherapy +/- Bevacizumab for the Treatment of Non-Small Cell Lung Cancer in the Phase II Study at ESMO Asia Congress 2022
2022-12-02 16:20
1294
Report
Share:
Share to wechat: